Recormon 500 Iu/0.3 M_. 2000 Iu/0.3 M_. 4 000 Iu/0.3 M_. 6 000 Iu/0.3 M_. 10 000 Iu/0.6 M_ 500 IU/0.3 m_. 2000 IU/0.3 m_. 4 000 IU/0.3 m_. 6 000 IU/0.3 m_. 10 000 IU/0.6 m_ Injection
PDF Leaflet Revision Date: 16 May 2024
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment of anemia in chronic kidney disease and cancer patients.
Dosage (summary)
Initial: 30,000 IU/week; adjust based on hemoglobin response.
Special Populations
- Renal impairment
- Cancer patients
- Premature infants
Pregnancy & Breastfeeding
Contraindicated during pregnancy and lactation.
Contraindications
- Hypersensitivity to epoetin beta
- Poorly controlled hypertension
- Recent myocardial infarction or stroke
Common side effects
- Hypertension
- Headache
- Thromboembolic events
Counselling Points
- Monitor blood pressure regularly
- Report any unusual symptoms
- Ensure adequate iron levels
Serious warnings
- Increased risk of death and thromboembolic events
- Monitor hemoglobin levels closely
Important Disclaimer
The Recormon 500 Iu/0.3 M_. 2000 Iu/0.3 M_. 4 000 Iu/0.3 M_. 6 000 Iu/0.3 M_. 10 000 Iu/0.6 M_ 500 IU/0.3 m_. 2000 IU/0.3 m_. 4 000 IU/0.3 m_. 6 000 IU/0.3 m_. 10 000 IU/0.6 m_ Injection professional information leaflet below is the property of Roche Products and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
